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Summary
In previously published studies, we had demonstrated that hydrazine sulfate pretreatment protected
mice against the lethal effects ofendotoxin and that this protection was accompanied by a sustained
increase in hepatic phosphoenolpyruvate carboxykinase activity (Silverstein, R., C.A. Christoffersen,
and D.C. Morrison. 1989. Infect. Immun. 57:2072) . The same hydrazine sulfate pretreatment has
now been found to protect mice against endotoxin in the n-galactosamine model with an increase
in the endotoxin LD5o of approximately four orders of magnitude. Elimination of the pretreat-
ment period, or administration ofan additional dose ofD-galactosamine at the time of hydrazine
sulfate pretreatment, renders the mice refractory to the protection. Given the sensitivity of
phosphoenolpyruvate carboxykinase regulation to several hormones, we investigated the possibility
that protection may have been hormone mediated. In addition to determining the effect ofhydrazine
sulfate on the plasma levels ofphosphoenolpyruvate carboxykinase regulating hormones, we have
investigated the effects of hydrazine sulfate on endotoxin lethality in mice whose capacity to
respond hormonallyto external stimuli has been compromised by hypophysectomy. Our results show
a significant enhancement in circulating levels of plasma corticosterone 30 min after hydrazine
sulfate injection. Moreover, hypophysectomy results in a marked increase in sensitivity of mice
to endotoxin challenge as well as an abrogation of the protection against endotoxin lethality
mediated by hydrazine sulfate. Although hydrazine sulfate protection distinguishes between
sensitivity brought on, individually, by n-galactosamine and by hypophysectomy, mice sensitized
by both hypophysectomy and D-galactosamine are not protected against endotoxin lethality by
hydrazine sulfate. We conclude that hydrazine sulfate protection against endotoxin lethality is
endocrine dependent, with the available evidence implicating a pituitary/adrenal axis, with
glucocorticoid involvement . In as much as D-galactosamine is known to act directly in the liver
in disrupting protein synthesis, it is proposed that events in the liver are critical to the hydrazine
sulfate-mediated protection against endotoxin and are possibly the target of the endocrine
involvement. Hydrazine sulfate pretreatment also protects n-galactosamine-sensitized mice against
the lethal effects of injected tumor necrosis factor/cachectin.
acterial endotoxins have been implicated as a major factor
in the pathogenesis of Gram-negative septic shock, a clin-
ical problem with significant morbidity and mortality (1-3).
Many experimental animal models of endotoxin lethality have
been established, with the objectives of understanding not
only the pathogenicmechanisms involved, but also potential
therapeutic approaches to reverse the deleterious pathophysio-
logic effects of this potent bacterial product. A number of
agents have been examined in terms of addressing the acute
lethal effects ofendotoxin, including glucocorticoids (4), an-
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tibody to endotoxin (LPS) (5), and antibody to TNF/cachectin
(6, 7). Our laboratory has recently reported that a dose of
30-80 mg/kg hydrazine sulfate given 5 h before challenge
will protect these animals against the lethal effects of an
LD5o-.8o dose of endotoxin (8). In that study, it was also es-
tablished that hydrazine sulfate pretreatment had the effect
of maintaining hepatic phosphoenolpyruvate carboxykinase
(EC4.1.1.32) (PEPCK)t activity after endotoxin challenge.
I Abbreviation used in thispaper: PEPCK, phosphoenolpyruvate carbosykinam
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the levels ofhepatic PEPCK were significantly depressed (8),
consistent with the well-established observations of the late
Professor Berry and colleagues (9, 10) . Indeed, our interest
in hydrazine sulfate was initially based on these findings cou-
pled with an earlier observation that hydrazine sulfate injec-
tion of normal rats led to an increase in hepatic PEPCK upon
isolation (11) . As to the relationship of these observations
to possible mechanisms ofhydrazine sulfate protection against
endotoxin, two possibilities were discussed in our previous
report : (a) that the increase inPEPCK might act against the
hypoglycemia associated with endotoxin shock ; and (b) that
the elevation ofPEPCK might have been hormonally induced
(8). Although protecting doses ofhydrazine sulfate were found
to have little effect on plasma glucose (8), the possibility re-
mained that hydrazine sulfate elevation of hepatic PEPCK
might have been hormonally induced. In this regard, it is
well established that PEPCK transcription is subject to regu-
lation by glucocorticoid, insulin, glucagon, and thyroid hor-
mone (12-15) . If the hydrazine sulfate-stimulated increase
in PEPCK was hormonally induced, then the observed pro-
tection might also have been hormonally induced. We there-
fore began the present study by examining for possible effects
of hydrazine sulfate effects on plasma corticosterone, triio-
dothyronine, insulin, and glucagon . This, in turn, led to a
comparison of the effects of hydrazine sulfate on mice sensi-
tized to the lethal effects of endotoxin through hypophysec-
tomy and/or D-galactosamine. The latter is increasingly being
applied as a model of endotoxin and TNF/cachectin sensiti-
zation and of liver injury (16-21) . Additional experiments
then focused on the properties ofthe hydrazine sulfate pretreat-
ment period, and on hydrazine sulfate protection against chal-
lenge from injected TNF/cachectin .
Materials and Methods
Animals. CF, females were obtained from Charles River
Breeding Laboratories, Inc. (Wilmington, MA) . They were of the
same age and housed under the same conditions as in our previous
report (8) . In some experiments, as specified, C3H/He (C3He/BK)
female mice were used . These were obtained from Bantin and
Kingman Labs (Freemont, CA) . They are a derivative of the
C3H/HeJ strain manifesting the same phenotypic hyporesponsive-
ness to endotoxin . The C3H/He mice used in these experiments
express the endotoxin nonresponder phenotype and are therefore
essentially equivalent to the C3H/HeJ strain provided by The
Jackson Laboratories (Bar Harbor, ME) . Due to the fire at The
Jackson Laboratories last year, C3H/HeJ mice were not available
at the time these studies were conducted, and an alternate vendor
was used .
Plasma Hormone and Glucose Levels.
￿
Mice were decapitated and
blood was drained into heparin- and aprotinin-containing tubes .
Plasma was obtained as previously described (8) . For each datum,
blood was taken from 12 mice into four pools, each from three
individual mice. This allowed for sufficient plasma to reliably assay
for glucagon, insulin, and corticosterone using commercial RIA
kits . The glucagon, triiodothyronine, and insulin kits were from
Cambridge Medical Technologies (Cambridge, MA), and the one
for corticosterone was from ICN Biomedicals (Carson, CA) . Rat
insulin standard was used in the insulinRIA and was obtained from
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Ronald Chance, Lilly Research Labs (Indianapolis, IN) . Significance
of the triiodothyronine data was confirmed withRIAAID (Cam-
bridge Medical Technologies) . Plasma glucose was determined by
the coupled enzyme assay method as previously described (8) .
Hypophysectomy and Recovery,
￿
Before surgery, mice were anesthe-
tized with 350 mg/kg Avertin . After swabbing with 70% eth-
anol, a 1-cm incision was made in the skin of the ventral neck re-
gion, and the salivary glands were retracted . The stemohyoideus
muscle was penetrated with a crossacting curved forceps and the
basisphenoid bone exposed . A hole (no. 6 burr) was drilled at
the junction between the occipital and the basisphenoid bones and
the underlying anterior pituitary was removed by negative pres-
sure. Thewound was closed by a9-mm would clip. Sham-operated
mice underwent the same procedure except the hole in the bone
was not drilled . After surgery, the animals were placed back on
feed, and were given water supplemented with 5% dextrose . By
48 h, plasma corticosterone levels were undetectable. At the con-
clusion of experiments, see below, and after death of the animal
by cervical dislocation, the skull was opened and completeness of
hypophysectomy confirmed by use of 4 x magnification . Animals
with pituitary remnants were excluded from the study. Failure rate
did not exceed 5% .
Lethality Studies .
￿
Mice were taken off feed at 10 pm, and then
challenged with endotoxin at 1 pin the next afternoon, at which
time they were also placed back on feed . Mice that had been
hypophysectomized or sham operated were treated similarly and
were allowed 60 h to recover from surgery before lethality study.
Dextrose supplementation for thesemice was withdrawn from the
drinking water at the start of the fasting period and was resumed
at the time of challenge and refeeding . For the lethality studies
with n-galactosamine-treated mice, the same fasting/challenge times
were used as above, with D-galactosamine given along with endo-
toxin or TNF/cachectin at the time ofchallenge. Lethalitywas moni-
tored for 48 h .
Chemicals.
￿
Hydrazine sulfate andD-galactosamine were obtained
from Sigma Chemical Co. (St . Louis, MO) . The D-galactosamine
was added with LPS (sonicated) or TNF/cachectin as a solution
of 45 mg/ml D-galactosamine in freshly prepared (from the solid
sodium phosphates) PBS, such that each mouse received 18 mg
(per 25 g body weight) D-galactosamine in 0.4 ml, as prescribed
by Lehmann et al . (16) . The LPS from Salmonella enteritidis, ex-
tracted by aqueous phenol (22), was purchased from Difco Labora-
tories (Detroit, MI) . Human recombinant TNF/cachectin was
generously provided by Chiron Corp. (Emeryville, CA) as purified
by Dr. George Kuo.
Statistics.
￿
X z contingency tables (23) were used to assess the
significance of hydrazine sulfate protection on endotoxin lethality.
The plasma hormone and glucose data are presented as plus or minus
the SEM, with p values determined by Student's t test (24) .
Results
The animal model that we have developed to study hydra-
zine sulfate protection against septic shock in normal mice
has been described previously (8) . In these studies, we estab-
lished that injection ofhydrazine sulfate before endotoxin chal-
lenge was necessary to observe protective effects, with a 5-h
pretreatment period being used in most experiments . To assess
potential hydrazine sulfate-mediated hormonal effects during
the critical pretreatment period between hydrazine sulfate ad-
ministration and endotoxin challenge, we have monitored the
plasma levels ofcorticosterone, triiodothyronine, insulin, andz 0
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glucagon in normal fasted CF1 mice, at various times after
injection of the hydrazine sulfate . Fasting and injection times
simulated those of the lethality studies. All determinations
were performed on the same blood samples, as described in
Materials and Methods . Significant differences were seen in
plasma corticosterone and triiodothyronine levels, during
different time periods, and in opposite directions. At 30 min,
the corticosterone level of the hydrazine sulfate-treated mice
was increased to 41.8 ± 1.9 jig/dl compared with 16.0 ±
0.1 ug/dl for saline-treated controls (p < .005) (Fig. 1) . The
level of triiodothyronine was unaffected for 2 h, and then,
unexpectedly, began to decrease. At 4 h, it was 1.86 ± 0.36
,ug/dl vs. 3.80 ± 0.50 /4g/dl for controls (p< .05), and again
at 5 h, it was 1.81 ± 0.51 hag/dl vs . 3 .92 ± 0.37 Ag/dl for
controls (p < .05) (Fig. 2) . The differences in glucagon and
insulin at each of the time points throughout the pretreat-
ment period were<30%, random in direction, and, in each
instance, statistically insignificant (p > 0.5) . These results
indicate that hydrazine sulfate can, in fact, significantly
influence circulating levels of plasma hormones during the
critical 5-h period before endotoxin challenge.
Given these differences in corticosterone and triiodothyro-
nine plasma levels between hydrazine sulfate- and saline-
pretreated mice, experiments were then carried out to assess
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Figure 2 .
￿
Effect of hydrazine sulfate on plasma triiodothyronine levels
during thepretreatment period. Sameplasma samples as in Fig. 1, t SEM ;
4h(p<0.05),5h(p<0.05) .
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Figure 3 .
￿
(A) Endotoxin lethal dose response for hypophysectomized
mice. (O) 25 fag; (" ) 1.0; (A) 0 .5 Ag; (") 0 .1 Ag. Seven mice per dose.
(b) Effect ofendotoxin dose, in parentheses, on lethality kinetics . Control
mice, intact . Data from reference 8. Hypophysectomized mice, from a .
the effects of removing the anterior pituitary on the murine
response to endotoxin, and then the potential capacity ofhydra-
zine sulfate to modulate that response . The response of
hypophysectomized mice to challenge with various doses of
endotoxin is shown in Fig. 3 a and establishes an LD5o of
-0.2 hg . This contrasts with the normal LD50 of -200 p,g
(8) . When the temporal course of the lethality response of
hypophysectomized mice to endotoxin is compared with the
equivalent responses for normal mice (Fig. 3 b) a three-order
of magnitude decrease in the LD5o can be readily appre-
ciated, even though, as shown in Fig . 3 b, the crisis period
for lethality at or near the LD5o remains 24-36 h after en-
dotoxin challenge for both groups of animals . Thus, hy-
pophysectomized mice, as had earlier been shown for adrenalec-
tomized mice (25, 26), are significantly increased in sensitivity
to endotoxin .
We next wished to assess the effects of hydrazine sulfate
in preventing endotoxin lethality in hypophysectomized mice.
An important concern before administration of hydrazine sul-
fate to hypophysectomized mice is that of potential hydra-
zine toxicity. In particular, hydrazine sulfate in sufficient dose
is capable ofproducing marked hypoglycemia beginning soon
after its administration, most likely due to its well-recognized
effects on PEPCK (11) . The hypoglycemia is then either rap-
idly reversed or results in the death of the animal . Although
we have not earlier observed significant effects of hydrazine
sulfate on glucose levels in intact mice given protecting doses
of hydrazine sulfate, it does not necessarily follow that these
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Figure 4 .
￿
Effect of50 mg/kg hydrazine sulfate on plasma glucose during
the pretreatment period . Control, sham operated. Five mice per datum,
± SEM.
same doses ofhydrazine sulfate may not adversely affect plasma
glucose levels in hypophysectomized mice. Accordingly, plasma
was obtained from hypophysectomized mice both before and
at various times after injection with hydrazine sulfate under
conditions simulating the pretreatment phase of the earlier
described hydrazine sulfate protection studies . The mice had
been hypophysectomized and then allowed to recover for 60 h .
They were then fasted overnight and through the 5 h after
the hydrazine sulfate injection exactly as described earlier. As
shown in Fig . 4, the effect of removing the pituitary is to
bring about a not unexpected reduction in plasma glucose
in the fasted mice, from 156 ± 8 mg/dl to 103 ± 8 mg/dl .
These differences are reflected in the time zero (pre-hydrazine
sulfate treatment) data . Further, it is evident that injection
of 50 mg/kg hydrazine sulfate does not result in any addi-
tional decrease in plasma glucose, nor are these combined
treatments lethal to the mice. All hypophysectomized- and
hydrazine sulfate-treated mice survived (10/10) without notice-
ably adverse effect for 2 wk after hydrazine sulfate, at which
time they were killed.
Table 1 .
￿
Effect of Hydrazine Sulfate on Endotoxin Lethality in
Hypophysectomized Mice
Mice were hypophysectomized and allowed to recover, and then fasted,
as described in Materials and Methods . Pretreatment with hydrazine sul-
fate, 5 h . Endotoxin, 0.2 p,g . Controls were pretreated with the saline
vehicle .
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Having established that hypophysectomized mice are
markedly increased in sensitivity to endotoxin, and that hydra-
zine sulfate treatment of such mice at a dose of 50 mg/kg
does not compound the hypoglycemia associated with
hypophysectomy, we next investigated whether hydrazine sul-
fate would reduce lethality due to endotoxin in these
hypophysectomized mice, otherwise using the same ex-
perimental conditions as in our previous model for protec-
tion . As is clear from the results of the several experiments,
which have been summarized in Table 1, hydrazine sulfate
at a variety of doses is unable to provide appreciable protec-
tion to hypophysectomized mice against an LD5o dose of en-
dotoxin. This is in marked contrast to our earlier published
data with normal mice, in which hydrazine sulfate provided
complete protection against an endotoxin LD50 over a dose
range of 30-80 mg/kg hydrazine sulfate (8) .
While these results are consistent with hydrazine sulfate
protection being hormone mediated, the possibility exists that
sensitization of mice to endotoxin might abrogate the pro-
tective effects of hydrazine sulfate. In that regard, D-galac-
tosamine is well recognized for its capacity to sensitize mice
to endotoxin to an even greater extent than does hypophysec-
tomy. Moreover, its immediate effects are hepatospecific (27)
and result from uridine nucleotide depletion (28) . In prelim-
inary experiments, we confirmed that D-galactosamine given
at the time of endotoxin challenge (and in the absence of
hydrazine sulfate treatment) lowers the LPS LDso by more
than four orders of magnitude (28) . We then explored the
effect of hydrazine sulfate, given 5 h before challenge, and
at a dose of 80 mg/kg . The results showed not only that
the protection was not abrogated in these D-galactosamine-
treated mice, but that the LD5o was raised by approximately
four orders of magnitude, approaching the LD5o seen in
normal mice (Fig. 5) . Further, the doses of hydrazine sulfate
in which protection first became apparent are similar to those
for hydrazine sulfate protection of normal, unsensitized mice
(8) . A comparison of this hydrazine sulfate dose-response
profile to that for hypophysectomized mice (Fig. 6) shows
dramatically the differences in response of the mice, depending
on the mode of endotoxin sensitization. It should be noted
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Figure 5 .
￿
Effect of 5-h, 80 mg/kg hydrazine sulfate pretreatment on
endotoxin lethality as seen from the LPS dose response profile . 18 mg
D-galactosamine was given at the time of challenge . Control, pretreated
with saline vehicle in place ofhydrazine sulfate . Six mice per datum . Not
shown are data showing full protection with 0.012, 0.1, and 1.0 ,tg LPS .
Hydrazine Sulfate Exp . 1
Lethality
Exp. 2
(deaths/total)
Exp . 3 Total
mg/kg
- 2/6 6/11 5/10 13/27
J
5 ND ND 5/11 5/11 tv
J
10 0/6 4/10 ND 4/16
20 ND ND 8/11 8/11
50 3/6 6/11 ND 9/17
160 6/6 ND ND 6/60 mg/kg
HS
Figure 6 .
￿
Comparative effects of hydrazine sulfate (HS) 5-h pretreat-
ment on endotoxin lethality in mice sensitized byhypophysectomy or with
D-galactosamine. Hydrazine sulfate dosage as shown, mg/kg HS . Endo-
toxin dose (LD5o) : hypophysectomy, 0 .2 Etg endotoxin ; D-galactosamine,
0.01 p.g endotoxin . Hypophysectomy data are taken from Table 1 .
ENDOTOXIN (lag)
Group
￿
A B C D
Hypophysectomy + - + -
D-Galoctosamine + + - -
Figure 7 .
￿
Effects ofhypophysectomy on endotoxin sensitivity in normal
and D-galactosamine-treated mice. Group A, D-galactosamine treated and
hypophysectomized ; group 13, D-galactosamine treated and sham operated;
group C, hypophysectomized ; group D, sham operated . Seven mice per
datum .
that the observed increase in lethality seen with the hypo-
physectomized mice given 20 mg/kg hydrazine sulfate (Fig .
6) is probably not statistically significant, and is not manifest
at the increased hydrazine sulfate dose of 50 mg/kg . The
highest dose of hydrazine sulfate may, however, be toxic to
the hypophysectomized mice.
Given this marked difference in response to hydrazine sul-
fate depending on the mode of sensitization, the question
arises as to whether the two physiological states with respect
to endotoxin sensitivity are themselves completely distinct .
If so, the increased sensitivity to endotoxin elicited by
hypophysectomy, -103, and that elicited by D-galactosamine
treatment, -104 , together should elicit an increased sensi-
tivity to endotoxin on the order of 107 . As shown by the
data in Fig. 7, the observed LD5o for the hypophysectomized
and D-galactosamine-treated mice is -0.002 N.g, or only four-
fold lower than that for intact mice treated with D-galac-
tosamine. Thus, it would appear that there is considerable
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Figure 8.
￿
Effect of 5-h hydrazine sulfate pretreatment on endotoxin
lethality in mice sensitized by hypophysectomy and by treatment with
D-galactosamine . Control, pretreated with saline vehicle . Plus hydrazine
sulfate, 80 mg/kg . Seven mice per datum .
overlap in the endotoxin sensitization states produced, not-
withstanding the differences in the means of sensitization .
Given that the physiological states are so closely overlap-
ping in terms of endotoxin sensitivity, why was hydrazine
sulfate able to confer protection against one sensitization state,
but not against the other? Conceivably, hydrazine might pro-
tect by a pituitary-dependent mechanism, involving subse-
quent impact on the liver. Ifso, then hypophysectomy might
be expected to abrogate the protection whether or not mice
were treated with D-galactosamine at the time of endotoxin
challenge. If, however, hydrazine sulfate protection against
D-galactosamine sensitization were not dependent on the pi-
tuitary, then an increase in the endotoxin LD50 might re-
sult from hydrazine sulfate pretreatment ofmice that had been
both hypophysectomized and treated with D-galactosamine
at the time of challenge . Under such circumstances, the
LD5o might be expected to rise toward that seen in the ab-
sence of D-galactosamine treatment, i.e., 0.2 ug (Fig . 3 a),
an increase of -100-fold . As seen in Fig. 8, hydrazine sulfate
does not protect hypophysectomized mice from D-galactos-
TIME OF HYDRAZINE SULFATE INJECTION (hours)
RELATIVE TO ENDOTOXIN AT ZERO TIME
Figure 9.
￿
Effect of hydrazine sulfate pretreatment time on endotoxin
lethality . 18 mg D-galactosamine given at the time of challenge. (O) 50
mg/kg hydrazine sulfate profile, 0.01 wg endotoxin (10/12 deaths, saline
vehicle) . 12 mice per datum (two experiments, six mice each) . (") 80
mg/kg hydrazine sulfate profile, 0.015 ftg endotoxin (10/10 deaths, saline
vehicle) . Seven mice per datum .
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￿
Effect of D-Calactosamine Pretreatment on Hydrazine
Sufate Protection against LPS
D-GaIN, D-galactosamine ; HS, hydrazine sulfate . Pretreatment, 5 h be-
fore challenge . Hydrazine sulfate, 80 mg/kg; D-GaIN, 18mg ; LPS, 0.012
Fag . Lethality, 48 h .
p < 0.005 .
amine sensitization, as the hydrazine sulfate and control mice
exhibit superimposableLPS dose lethality profiles. Thus, the
ability of hydrazine sulfate to protect against endotoxin
lethality in both normal and D-galactosamine-sensitized mice
is pituitary dependent .
The possibility that a pituitary effect acting on the liver
might involve changes in hepatic protein levels, coupled with
the fact that D-galactosamine rapidly decreases hepatic pro-
tein synthesis (27), led us to explore the possibility that
D-galactosamine sensitization at the time of challenge and
hydrazine sulfate desensitization during the pretreatment
period might reflect closely related phenomena . Conceivably,
hydrazine sulfate might effect certain changes during the
pretreatment period that not only might be helpful to host
defense against endotoxin, but that might otherwise not occur
under the influence of simultaneous D-galactosamine treat-
ment . Accordingly, we ascertained whether or not hydrazine
sulfate pretreatment was, in fact, necessary for the protection
against D-galactosamine sensitization, and whether or not
injection of D-galactosamine not only at the time of endo-
Table 3.
￿
Effect ofHydrazine Sufate on TNF/Cachectin: Endotoxin Lethality
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toxin challenge but also at the start of the pretreatment period
might impact on that protection . Accordingly, hydrazine sul-
fatewas given to mice at different times before challenge with
endotoxin. The effect of hydrazine sulfate given at the same
time or after the time of endotoxin challenge was also as-
sessed . The data, shown in Fig . 9, confirm that a period of
hydrazine sulfate pretreatment is necessary for protection, and
document a requirement for pretreatment of the order of several
hours. Not shown in Fig. 9 are data with 80 mg/kg hydra-
zine sulfate given at 10 or 15 h before challenge. Protection
was still evident after these extended pretreatment times, with
a corresponding lethality of 0/7 and 1/7, respectively. Evi-
dence that the need for an extended time was not primarily
a reflection of time needed for hydrazine clearance from the
circulation was suggested by determination of hydrazine con-
centration in plasma after intraperitoneal injection of80 mg/kg
hydrazine sulfate. By 30 min after injection, plasma hydra-
zine concentration had peaked, and by 1 h, >75% of the
hydrazine had been cleared from the circulation (unpublished
data) .
Having established that hydrazine sulfate pretreatment is
necessary to the protection against D-galactosamine sensiti-
zation, we then investigated the effect ofD-galactosamine being
present at the start ofthe pretreatment period . D-Galactosamine
was given in two equal doses, each 18 mg. One dose was
given, as previously, at the time of challenge . The other, 5 h
before, was at the time of hydrazine sulfate pretreatment .
As shown by the cumulative results of two experiments, ad-
ministration ofD-galactosamine at the start ofthe 5-h pretreat-
ment period completely abrogated the protective effects of
hydrazine sulfate (Table 2) . Control experiments have estab-
lished that the lethality observed is not simply the result of
the mice receivingtwo doses of D-galactosamine alone, since
0/15 mice died under such conditions in the absence of
endotoxin . When this experiment was carried out under con-
ditions in which hydrazine sulfate was given 10 h before chal-
lenge, and 5 h before the first of the two doses of D-galac-
tosamine, protection was again readily apparent . This latter
CFl mice were treated with either 50 mg/kg hydrazine sulfate or saline vehicle 5 h before challenge with 0.5 Wg TNF/cachectin (Chiron Corp .)
or 0.04 ug Edtoxin . Mice were sensitized with 18 mg D-galactosamine given at the time of challenge . Lethality, 48 h .
Hydrazine Sulfate
mglkg
Challenge Exp . 1 Exp. 2
Lethality (deaths/total)
Exp . 3 Total
- None 0/5 0/6 0/6 0/17
50 None 0/6 0/6 ND 0/11
- TNF ND 5/8 2/2 7/10
p < 0.005
50 TNF ND 0/8 0/2 0/10
- Endotoxin 4/4 5/8 8/8 17/20 < 0.005
50 Endotoxin 2/5 2/8 0/7 4/20
p
Lethality (deaths/total)
Pretreatment Challenge Exp . 1 Exp . 2 Total
D-GaIN n-GaIN 0/5 0/10 0/15
D-GaIN LPS+D-GaIN 8/10 3/5 11/15
HS LPS+D-GaIN 1/5 1/10 2/15'
HS +D-GaIN LPS+D-GaIN 8/10 3/5 11/15"result eliminates the possibility that the two doses ofD-galac-
tosamine per se abrogated the protection, rather than their
relationship to the times of hydrazine sulfate and endotoxin
administration.
We then examined the possibility that since TNF/cachectin
has been implicated as a major contributing factor in the patho-
logical effects of endotoxin (6, 7), and D-galactosamine also
sensitizes mice to the lethal effects of TNF/cachectin (16),
hydrazine sulfate protection against endotoxin in D-galac-
tosamine-treated mice might also extend to protection against
TNF/cachectin itself. As shown in Table 3, hydrazine sulfate
pretreatment (50 mg/kg, -5 h) provided significant protec-
tion of mice against the lethal effects ofboth endotoxin and
TNF/cachectin . We also tested the ability of hydrazine sul-
fate to protect against TNF/cachectin in an endotoxin-resistant
strain. The C3H/HeJ endotoxin hyporesponsive mouse has
been reported to be at least 100-fold more resistant than normal
mice to the lethal effects of endotoxin in the D-galactosamine
model, while exhibiting no significant difference in sensitivity
to the lethal effects ofTNF/cachectin (16) . We have confirmed
these results with the C3H/HeBK strain used in our own
studies. Whereas the LDso for TNF/cachectin in D-galac-
tosamine-sensitized mice was 0.5 ug both forCF1 andC3H/
HeBK mice, the LDso for LPS in D-galactosamine-sensitized
mice was "0.005 p,g for CFl mice and -0.8 ixg for the
C3H/HeBK strain. We then queried whether hydrazine sul-
fate pretreatment (-5 h, 160 mg/kg) would protect these
LPS-hyporesponsive mice against challenge from an LDBO_y0
dose ofeither endotoxin or TNF/cachectin . In both instances,
significant (p < 0.005) protection was evident: againstTNF/
cachectin (0.6 hg), 9/10 vs . 0/6 deaths; and against LPS (1.2
lug), 5/6 vs . 0/6 deaths.
Discussion
Earlier studies from our laboratory established that pretreat-
ment of mice with hydrazine sulfate provided significant pro-
tection of these animals against subsequent challenge with
lethal doses of endotoxin . It was also shown that hydrazine
sulfate pretreatment acted to reverse the decrease in hepatic
PEPCK activity that follows endotoxin challenge, suggesting
a possible hormonal response to hydrazine sulfate that might
contribute to the observed protection (8) . In this report, we
have shown that hydrazine sulfate administration stimulates
an early increase in plasma corticosterone followed by a de-
crease in circulating triiodothyronine. Both of these hormones
are pituitary dependent and contribute to PEPCK regulation.
We then found that hypophysectomy abrogated the protec-
tion against endotoxin, providing strong evidence for the con-
cept that the protection was pituitary dependent . We then
determined that hydrazine sulfate protection was neverthe-
less not abrogated when mice were made sensitive to endo-
toxin upon treatment with the hepatotoxin D-galactosamine.
On the contrary, the endotoxin LDso was raised by approx-
imately four orders ofmagnitude, almost completely reversing
the D-galactosamine sensitization effect . Given the sharp differ-
ence in the capacity of hydrazine sulfate to protect depending
on the mode of sensitization, we explored to what extent
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the endotoxin sensitization states brought about by D-galac-
tosamine treatment and by hypophysectomy are mutually in-
dependent . Lethality studies in which mice were D-galac-
tosamine treated, hypophysectomized, or both, revealed strong
overlap on the endotoxin LD5o between the two modes of
sensitization . Further investigation of hydrazine sulfate pro-
tection of D-galactosamine-treated mice revealed that protec-
tion was abrogated after hypophysectomy, asshown also with
normal mice. Further, that the protection required several
hours of pretreatment, with a requirement that D-galac-
tosamine not be present during the pretreatment period .
These collective results are consistent with an hypothesis
in which hydrazine sulfate, either directly or indirectly, stimu-
lates increased pituitary/adrenal hormonal release. Key cel-
lular targets for these hormones are suggested to be hepato-
cytes and/or macrophages . Corticosteroid stimulation of
macrophages result in their decreased sensitivity to subsequent
endotoxin stimulation (29, 30) . Corticosteroids also have the
effect of stimulating the hepatocyte in response to endo-
toxin (31) .
Our results confirm and extend the results of several ear-
lier investigatorswho have examined hormonal effects on en-
dotoxin sensitivity in mice . Thus, as shown by Bertini et al .
(25), adrenalectomized mice are rendered highly susceptible
to the lethal effects of endotoxin, with an LDso comparable
with that reported here for hypophysectomized mice. Simi-
larly, as shown by Berry and Smythe (4), corticosteroids will
protect against endotoxin, if given before endotoxin challenge.
Our data of hydrazine-induced changes in circulating hor-
mone levels, abrogation of hydrazine protection against en-
dotoxin by hypophysectomy, and the marked protection con-
ferred by hydrazine sulfate against the endotoxin sensitization
arising from the hepatospecific toxin, D-galactosamine, sug-
gest a possible liver/pituitary link with respect to hydrazine
sulfate protection against endotoxin . It is also possible that
hydrazine may interfere, directly or indirectly, with endo-
toxin stimulation of the macrophage . In either case, the fact
that hypophysectomized/D-galactosamine-treated mice remain
totally refractory to hydrazine sulfate pretreatment indicates
that hydrazine sulfate-mediated modulation of pituitary/
adrenal function is most likely to be a critical factor in the
manifestation of the observed protection against endotoxin .
There is little question but that mononuclear phagocytes
play a critical role in mediating the lethal effects of endo-
toxin . In this regard, Galanos and colleagues (32) have adop-
tively transferred normal peritoneal macrophages into D-galac-
tosamine-treated C3H/HeJ endotoxin-hyporesponsive mice
and observed sensitivity to endotoxin indistinguishable from
control mice. Further, it has been established that macrophage-
derived TNF/cachectin is essential in mediating endotoxin
lethality (6, 7) . In this respect, therefore, it is perhaps note-
worthy that hydrazine sulfate pretreatment also has been found
to protect D-galactosamine-sensitized mice against the lethal
effects of TNF/cachectin . Since hepatocytes appear to be the
selective target for D-galactosamine, as discussed above, and
since pituitary/adrenal-derived hormonal factors from hydra-
zine sulfate-injected mice appear to reverse D-galactosamine
sensitization, we have speculated that hepatocytes may be thepivotal target cell for any prophylactic endocrine effect in-
duced by hydrazine sulfate pretreatment . If so, glucocorti-
coid involvement in this regard, and perhaps with hepatic
synthesis of acute phaseproteins (31), couldprovide a poten-
tially satisfying explanation for the protection observed by
us and others.
On the other hand, it is known that glucocorticoid pretreat-
ment of murine macrophages decreases their sensitivity to
endotoxin as measured by TNF/cachectin production. As
shown by Beutler et al. (29), glucocorticoid regulation of
TNF/cachectin secretion is manifest both at the levelof tran-
scription and translation. Moreover, consistent with the results
reported here and elsewhere, regulation of macrophage
TNF/cachectin production requires that cells be pretreated
with corticosteroids before LPS stimulation.
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